Abstract
Severe itching for unknown reasons has been reported after administration of hydroxyethylstarch (HES) in haemodilution therapy of humans. After HES treatment, vacuoles in cells of various organs in humans have been shown, predominantly affecting the mononuclear phagocyte system. These vacuoles present indirect evidence for phagocytosis of HES particles. Since phagocytosis is also known to occur in the skin, this organ might represent a target for HES deposition, resulting in subsequent release of mediators responsible for the observed itching. The aim of the present investigation was to study skin biopsies of patients, who had received HES and suffered subsequently from itch. Skin sections were investigated for morphological impairment by means of light and electron microscopy, immunohistochemistry and immunoelectron microscopy using a polyclonal anti-HES antiserum. Storage of HES was demonstrated in the skin of all patients, mainly in dermal macrophages, endothelial cells of blood and lymph vessels, some perineural cells and endoneural macrophages of larger nerve fascicles, some keratinocytes and Langerhans cells. Treatment with antihistaminic agents proved ineffective in these patients; this fits with the observation that morphological signs of histamine release from mast cells were absent. These findings indicate that other mediators from HES-affected cells must be responsible for the development of the itching. Thus, investigation of HES storage may be a useful contribution to the elucidation of release of itch mediators and induction of pruritus.
Similar content being viewed by others
References
Ansel J, Perry P, Brown J, Damm D, Phan T, Hart D, Luger T, Hefeneider S (1990) Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 94: 101S-107S
Csató M, Bozóky B, Hunyadi J, Dobozy A (1986) Candida albicans phagocytosis by separated human epidermal cells. Arch Dermatol Res 279: 136–139
Cullen MJ, Singer M (1990) Severe anaphylactoid reaction to hydroxyethyl starch. Anaesthesia 45: 1041–1042
Dienes HP, Gerharz CD, Wagner R, Weber M, John HD (1986) Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension. J Hepatol 3: 223–227
Dowd PM, Camp RDR, Greaves MW (1988) Effect of human recombinant IL-1 in normal human skin. Skin Pharmacol 1: 36–40
Foreman JC (1989) Peptides, neurogenic inflammation and itch. Skin Pharmacol 2: 220
HÄgermark O (1989) Histamine, serotonin, prostaglandins and cytokines. Skin Pharmacol 2: 219
Hermann J, Gall H (1990) Diognose und Therapie des persistierenden Pruritus nach Infusion von HydroxyÄthylstÄrke (HÄS). Aktuel Dermatol 16: 166–167
Hong B, Zhong T (1988) Studies on the side-effect of hydroxyethyl starch injections. Yaoxue Tongbao 23: 51
Hulse JD, Jacobi A (1983) An overview of the colloid and its metabolism. Drug Intell Clin Pharm 17: 334–341
Humphrey JH, Grennan D (1981) Different macrophage populations distinguished by means of fluorescent polysaccharides. Recognition and properties of marginal-zone macrophages. Eur J Immunol 11: 221–228
Hsu SM, Raine L, Fanger H (1981) Use of a avidin-biotin-peroxidase complex in immunoperoxidase techniques. J Histochem Cytochem 29: 577–580
Jarecki-Black JC, Atkins L, Pratt KM, Pepkowitz SH, Glassman AB (1986) Effect of hydroxyethyl starch (HES) in reducing parasite load in experimental visceral Leishmaniasis. Ann Clin Lab Sci 16: 450–454
Jesch F, Hubner G, Zumtobel V, Zimmermann M, Me\mer K (1979) Hyroxyethylstarke (HES 450/0.7) in Plasma und Leber. Konzentrationsverlauf und histologische VerÄnderungen beim Menschen. Infusionstherapie 6: 112–117
Kroemer H, Haa\ A, Müller K, JÄger H, Wagner EM, Heimburg P, Klotz U (1987) Hemodilution therapy in ischemic stroke: pharmacokinetics and plasma viscosity during long term infusion of dextran 40 or hetastarch 200/0.5. Eur J Clin Pharmacol 31: 705–711
Lindblad G, Falk J (1976) Konzentrationsverlauf von HydroxyÄthylstÄrke und Dextran in Serum und Lebergewebe von Kaninchen und die histopathologischen Folgen der Speicherung von HydroxyethylstÄrke. Infusionstherapie 2: 301–303
Me\mer K, Kreimeier U, Intaglietta M (1986) Present state of intentional hemodilution. Eur Surg Res 18: 254–263
Nakasato SK (1982) Evaluation of hetastarch. Clin Pharm 1: 509–514
Parker NE, Porter JB, Williams HJM, Leftley M (1982) Pruritus after administration of hetastarch. BMJ 284: 385–386
Parth E, Jurecka W, Szépfalusi Z, Schimetta W, Gebhart W, Scheiner O, Kraft D (1992) Histological and immunohistochemical investigations of hydroxyethylstarch deposits in rat tissues. Eur Surg Res 24: 13–21
Potter B, Medenica M (1968) Ultramicroscopic phagocytosis of synthetic melanin by epidermal cell in vivo. J Invest Dermatol 51: 300–303
Ramono EL, Ramono M (1977) Staphylococcal protein A bound to colloidal gold: a useful reagent to label antigenantibody sites in electron microscopy. Immunochemistry 14: 711–715
Richter W, Hedin H (1983) Solutions and emulsions used for intravenous infusions. In: Weck AL de, Bundgaard H (eds) Handbook of experimental pharmacology, vol 63. Springer, Berlin Heidelberg New York, pp 581–626
Richter W, deBelder AN (1976) Antibodies against hydroxyethylstarch produced in rabbits by immunization with a protein hydroxyethylstarch conjugate. Int Arch Allergy Appl Immunol 52: 307–314
Ring J, Me\mer K (1977) Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet I: 466–469
Schneeberger R, Albegger K, Oberascher G, Miller K (1990) Juckreiz — eine Nebenwirkung von HydroxyÄthylstÄrke (HES)? HNO 38: 298–303
Sirtl C, Laubenthal H, Dieterich HJ, Hugler P, Peter K (1990) Nebenwirkungen von künstlichen kolloidalen Plasmaersatzmitteln unter besonderer Berücksichtigung von HydroxyethylstÄrke (HES). Beitr Anaesth Intensivmed 31: 35–53
Thompson WL, Fukushima T, Rutherford RB, Walton RB (1970) Intravascular persistence, tissue storage and excretion of hydroxyethylstarch. Surg Gynecol Obstet 131: 965–972
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jurecka, W., Szépfalusi, Z., Parth, E. et al. Hydroxyethylstarch deposits in human skin — a model for pruritus?. Arch Dermatol Res 285, 13–19 (1993). https://doi.org/10.1007/BF00370817
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00370817